Alabama · 2026 Regular Session · Resolution

HJR 162: Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings

Enacted Last action March 13, 2026: Enacted

Plain-language summary

HJR 162 is a resolution introduced in the Alabama House on February 24, 2026. According to its official title, it concerns: Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings. Primary sponsor: Ed Oliver (Republican). Most recent recorded action (March 13, 2026): Enacted.

Sponsors

Primary sponsor: Ed Oliver (Republican).